Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03060343 · UNKNOWN
Trial details
- NCT number
- NCT03060343
- Sponsor
- Yu Fenglei
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2018-11-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.